glp-1 agonist therapy consultation preparation GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach GLP-1 Receptor Agonists as Treatments
Description
Kim HJ, Jeong S, Oh YH, Park SJ, Cho Y, Park SM

The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function

Statements Author contributions QF: Formal analysis, Writing original draft, Conceptualization, Investigation

That distinction could drive wider use among people with obesity who have struggled to access newer and often more expensive branded drugs

An elevated resting heart rate can increase long-term cardiovascular risk, and regulators need robust data confirming that the metabolic benefits outweigh this potential downside

Influence of maternal body mass index on pregnancy complications and outcomes: a systematic review and meta-analysis
